Syringe listings can help clarify the available product options, including barrel size, markings, needle style, and detachable-needle compatibility
The goal is improving long-term health, not simply achieving short-term weight loss
IV fluids if vomiting prevents oral intake Red-flag threshold / inability to keep any liquids down for more than 24 hours requires same-day clinical evaluation Key electrolytes at risk / sodium, potassium, and chloride can fall with severe or prolonged vomiting and diarrhea Dose relationship / GI side effects peak during dose escalation and often improve after 4-8 weeks at a stable dose Concurrent risk / patients on diuretics, SGLT-2 inhibitors, or ACE inhibitors face compounded dehydration risk Why GLP-1 Drugs Cause Dehydration in the First Place GLP-1 receptor agonists work partly by slowing gastric emptying and acting on brainstem nausea centers
Synthesis and evaluation of potent KCNQ2/3-specific channel activators
Current data suggest that GLP-1s are generally safe for long-term use when prescribed appropriately and monitored by a licensed provider
